| Primary |
| Off Label Use |
23.0% |
| Postoperative Care |
22.8% |
| Preoperative Care |
11.6% |
| Photorefractive Keratectomy |
6.7% |
| Hypertension |
5.1% |
| Antibiotic Prophylaxis |
4.5% |
| Back Disorder |
2.8% |
| Conjunctivitis |
2.8% |
| Product Used For Unknown Indication |
2.8% |
| Prophylaxis |
2.8% |
| Glaucoma |
2.2% |
| Ulcerative Keratitis |
2.0% |
| Blood Cholesterol Increased |
1.6% |
| Conjunctivitis Bacterial |
1.6% |
| Eye Infection |
1.6% |
| Intraocular Pressure Increased |
1.6% |
| Cataract Operation |
1.4% |
| Cardiac Disorder |
1.2% |
| Corneal Abrasion |
1.2% |
| Keratitis Bacterial |
1.2% |
|
| Impaired Healing |
15.4% |
| Ocular Hyperaemia |
10.8% |
| Vision Blurred |
9.2% |
| Eye Irritation |
7.7% |
| Ulcerative Keratitis |
6.9% |
| Endophthalmitis |
6.2% |
| Visual Acuity Reduced |
6.2% |
| Corneal Abrasion |
4.6% |
| Eye Pain |
4.6% |
| Inappropriate Schedule Of Drug Administration |
4.6% |
| Corneal Disorder |
3.1% |
| Corneal Epithelium Defect |
3.1% |
| Corneal Infiltrates |
3.1% |
| Conjunctival Hyperaemia |
2.3% |
| Corneal Oedema |
2.3% |
| Hypersensitivity |
2.3% |
| Iritis |
2.3% |
| Keratitis |
2.3% |
| Blood Urine Present |
1.5% |
| Corneal Opacity |
1.5% |
|
| Secondary |
| Off Label Use |
16.9% |
| Postoperative Care |
16.4% |
| Hypertension |
14.8% |
| Preoperative Care |
7.8% |
| Cardiac Disorder |
6.9% |
| Post Procedural Complication |
6.9% |
| Photorefractive Keratectomy |
6.0% |
| Antibiotic Prophylaxis |
5.5% |
| Intraocular Pressure Increased |
4.3% |
| Blood Cholesterol Increased |
3.8% |
| Keratitis Bacterial |
3.5% |
| Ulcerative Keratitis |
1.6% |
| Prophylaxis |
1.2% |
| Cataract Operation |
1.1% |
| Back Disorder |
1.0% |
| Product Used For Unknown Indication |
0.7% |
| Vitamin Supplementation |
0.4% |
| Corneal Abrasion |
0.4% |
| Eye Infection |
0.4% |
| Blepharitis |
0.3% |
|
| Toxic Anterior Segment Syndrome |
18.1% |
| Impaired Healing |
10.4% |
| Endophthalmitis |
8.1% |
| Visual Acuity Reduced |
8.1% |
| Ocular Hyperaemia |
6.8% |
| Ulcerative Keratitis |
5.9% |
| Corneal Disorder |
5.4% |
| Vision Blurred |
4.5% |
| Mydriasis |
4.1% |
| Corneal Epithelium Defect |
3.6% |
| Nausea |
3.6% |
| Eye Irritation |
3.2% |
| Corneal Abrasion |
2.7% |
| Corneal Infiltrates |
2.7% |
| Eye Pain |
2.7% |
| Keratitis |
2.7% |
| Inappropriate Schedule Of Drug Administration |
2.3% |
| Corneal Opacity |
1.8% |
| Hypersensitivity |
1.8% |
| Corneal Oedema |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Cataract Operation |
10.3% |
| Chronic Obstructive Pulmonary Disease |
10.3% |
| Postoperative Care |
7.7% |
| Anxiety |
5.1% |
| Hordeolum |
5.1% |
| Systemic Lupus Erythematosus |
5.1% |
| Age-related Macular Degeneration |
2.6% |
| Blood Glucose Abnormal |
2.6% |
| Blood Pressure Increased |
2.6% |
| Colitis Ulcerative |
2.6% |
| Eye Swelling |
2.6% |
| Infection Prophylaxis |
2.6% |
| Insomnia |
2.6% |
| Metastases To Bone |
2.6% |
| Metastases To Lung |
2.6% |
| Metastases To Pleura |
2.6% |
| Multiple Myeloma |
2.6% |
| Neoplasm Of Thymus |
2.6% |
| Plasma Cell Myeloma |
2.6% |
|
| Vitreous Haemorrhage |
16.7% |
| Intraocular Pressure Increased |
11.1% |
| Systemic Lupus Erythematosus |
11.1% |
| Corneal Transplant |
5.6% |
| Death |
5.6% |
| Deep Vein Thrombosis |
5.6% |
| Dysgeusia |
5.6% |
| Impaired Healing |
5.6% |
| Pain |
5.6% |
| Photophobia |
5.6% |
| Rectal Haemorrhage |
5.6% |
| Swollen Tongue |
5.6% |
| Urticaria |
5.6% |
| Vision Blurred |
5.6% |
|
